Discounted Cash Flow
Nerdwallet, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | $228.3m | $24.2m | $30.7m | 10.6% | $0.57 |
| 2020 | $245.3m (7.4%) | $5.3m (-78.1%) | $14.1m (-54.1%) | 2.2% (-79.6%) | $0.12 (-79.2%) |
| 2021 | $379.6m (54.7%) | $-42.5m (-901.9%) | $4.9m (-65.2%) | -11.2% (-618.2%) | $-0.82 (-784.5%) |
| 2022 | $538.9m (42.0%) | $-10.2m (76.0%) | $20.4m (316.3%) | -1.9% (83.1%) | $-0.14 (82.4%) |
| 2023 | $599.4m (11.2%) | $-11.8m (-15.7%) | $71.4m (250.0%) | -2.0% (-4.0%) | $-0.15 (-6.5%) |
| 2024 | $687.6m (14.7%) | $30.4m (357.6%) | $71.2m (-0.3%) | 4.4% (324.6%) | $0.40 (358.3%) |
| 2025 | $836.6m (21.7%) | $48.7m (60.2%) | $130.3m (83.0%) | 5.8% (31.7%) | $0.66 (64.9%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.